Coherus BioSciences (NASDAQ:CHRS) Stock Rating Lowered by StockNews.com
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. CHRS has been the topic of several other reports. HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares […]
Coherus BioSciences (NASDAQ:CHRS – Get Free Report) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday. CHRS has been the topic of several other reports. HC Wainwright reissued a “buy” rating and issued a $7.00 price target on shares […]
